...if you connect the dots...$35k payment to GMU Labs (for cost associated with more tests) to build up Data Base establishing and supporting the dynamic virus destruction capabilities of Brilacidin...even beyond the Covid-19...
...could lead to expedited FDA approval for Covid-19 human trials...and would require only $4M to run its own Human Trials...(and in conjunction with a FL or TX teaching hospital?)
Not difficult to achieve and do, if TEST DATA expands and supports the evidence thus far.
I even "fantasized" about something more extreme (that would probably never happen).. I am invested in a few private companies.. and it is amazing how easy it is for some of these companies to raise non toxic funding - one company I'm invested in did a capital raise of 20 million and another is in the process of raising 50 million. Since the Jobs Act of 2015? (not sure of the year) - non accredited investors are allowed to invest in these types of companies, so it wouldn't be an issue of having a different investor class.
Anyway, get the money (and as you say) get it done - and then have an exit strategy (just like a private company has the goal of either a buyout or a listing on a major exchange)..
I like the way you think:)..
hopefully my example makes sense.. in that even though it may be unrealistic for us to go private at this time.. its similar thinking to what you suggest.
I believe the current situation were in will present opportunities.. hopefully Leo navigates us to the best opportunity available.